Shares of Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $23.52 and last traded at $23.00, with a volume of 50870 shares. The stock had previously closed at $23.04.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. initiated coverage on Ascentage Pharma Group International in a research report on Thursday, March 27th. They issued an "overweight" rating for the company.
View Our Latest Stock Report on Ascentage Pharma Group International
Ascentage Pharma Group International Trading Down 2.6 %
The business's 50 day simple moving average is $19.62.
About Ascentage Pharma Group International
(
Get Free Report)
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Recommended Stories
Before you consider Ascentage Pharma Group International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascentage Pharma Group International wasn't on the list.
While Ascentage Pharma Group International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
